FDA Approval: Sunvozertinib in EGFR Exon 20 NSCLC

Podcast | English | 2025 | 41 Min

Create Account

Cost

$0.00

Credit

No Credit Offered

In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses EGFR exon 20 insertions and the recently approved targeted therapy for this subset of lung cancer: sunvozertinib. Dr. Mariam Alexander and Dr. James Chih-Hsin Yang join the conversation to help review the data and offer expertise and perspective on this new agent.

Podcast Host:

Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA

Podcast Guests:

James Chih-Hsin Yang, MD, PhD, Distinguished Professor, Graduate Institute of Oncology, National Taiwan University; Director, National Taiwan University Cancer Center, Taipei, Taiwan
Mariam Alexander, MD, Thoracic Medical Oncologist, Assistant Professor of Medicine, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA